Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from M3 ( (JP:2413) ).
M3, Inc. announced the status of its share repurchase program, which was approved by its Board of Directors in May 2025. During September 2025, the company repurchased 127,800 common shares for approximately 297.98 million yen through open market purchases on the Tokyo Stock Exchange. This initiative is part of a broader strategy to buy back up to 20 million shares, with a maximum budget of 20 billion yen, by April 2026. The repurchase aims to enhance shareholder value and optimize the company’s capital structure.
The most recent analyst rating on (JP:2413) stock is a Buy with a Yen2800.00 price target. To see the full list of analyst forecasts on M3 stock, see the JP:2413 Stock Forecast page.
More about M3
M3, Inc. operates in the healthcare industry, primarily focusing on providing medical-related services and solutions. The company is known for its online medical platforms and services, which cater to healthcare professionals and institutions.
Average Trading Volume: 3,859,347
Technical Sentiment Signal: Hold
Current Market Cap: Yen1601.9B
For detailed information about 2413 stock, go to TipRanks’ Stock Analysis page.